BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35385606)

  • 1. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
    McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
    Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
    Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
    Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
    Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
    [No Abstract]   [Full Text] [Related]  

  • 5. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
    Vuong HG; Ngo TNM; Dunn IF
    J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
    Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
    World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
    Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
    Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
    Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
    Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
    J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
    Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
    J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38518294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
    Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
    Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy.
    Ni G; Pinheiro-Neto CD; Iyoha E; Van Gompel JJ; Link MJ; Peris-Celda M; Moore EJ; Stokken JK; Gamez M; Choby G
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.
    Goshtasbi K; Abiri A; Abouzari M; Sahyouni R; Wang BY; Tajudeen BA; Hsu FPK; Cadena G; Kuan EC
    Int Forum Allergy Rhinol; 2019 Sep; 9(9):1054-1062. PubMed ID: 31251848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma.
    Kaur G; Kane AJ; Sughrue ME; Madden M; Oh MC; Sun MZ; Safaee M; El-Sayed I; Aghi M; McDermott MW; Berger MS; Parsa AT
    J Clin Neurosci; 2013 Feb; 20(2):281-6. PubMed ID: 23266076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
    Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
    Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.
    Li R; Tian S; Zhu Y; Yan L; Zhu W; Quan H; Wang S
    Radiat Oncol; 2019 Jun; 14(1):107. PubMed ID: 31196122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.
    Wu K; Avila SA; Bhuyan R; Matloob A; Del Signore AG; Hadjipanayis C; Chelnis J
    Orbit; 2022 Feb; 41(1):1-14. PubMed ID: 33317383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
    Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
    Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.